References: | 1.Nieder C, Spanne O, Mehta MP, Grosu AL, Geinitz H. Presenta-
tion, patterns of care, and survival in patients with brain metasta-
ses: what has changed in the last 20 years? Cancer. 2011;117:
2505-2512.
2. Tabouret E, Chinot O, Metellus P, Tallet A, Viens P, Gonçalves A.
Recent trends in epidemiology of brain metastases: an overview. Anti-
cancer Res. 2012;32:4655-4662.
3. Sundermeyer ML, Meropol NJ, Rogatko A, Wang H, Cohen SJ. Chang-
ing patterns of bone and brain metastases in patients with colorectal
cancer. Clin Colorectal Cancer. 2005;5:108-113.
4. Michl M, Thurmaier J, Schubert-Fritschle G, et al. Brain metastasis in
colorectal cancer patients: survival and analysis of prognostic factors.
Clin Colorectal Cancer. 2015;14:281-290.
5. Sperduto PW, Kased N, Roberge D, et al. Summary report on the
graded prognostic assessment: an accurate and facile diagnosis-
specific tool to estimate survival for patients with brain metastases.
J Clin Oncol. 2012;30:419-425.
6. Kye BH, Kim HJ, Kan g WK , Cho HM, Hong Y K, Oh S T.
Brain metastases f rom colo rectal cancer: the role of surgical
resectioninselectedpatients.Colorectal Dis. 2012;14:e378-e385.
7. Kalkanis SN, Kondziolka D, Gaspar LE, et al. The role of surgical
resection in the management of newly diagnosed brain metastases:
a systematic review and evidence-based clinical practice guideline.
J Neurooncol. 2010;96:33-43.
8. Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic
radiosurgery in the management of patients with newly diagnosed
brain metastases: a systematic review and evidence-based clinical
practice guideline. J Neurooncol. 2010;96:45-68.
9. Damiens K, Ayoub JPM, Lemieux B, et al. Clinical features and course
of brain metastases in colorectal cancer: an experience from a single
institution. Curr Oncol. 2012;19:254-258.
10. Nieder C, Pawinski A, Balteskard L. Colorectal cancer metastatic to
the brain: time trends in presentation and outcome. Oncology. 2009;
76:369-374.
11. Zoratto F, Loupakis F, Cremolini C, et al. Long-survivors with lung
metastases and kras mutations have an increased risk to develop
brain metastases from colorectal cancer. Ann Oncol. 2013;24:
iv11-iv24.
12. Qiu M, Hu J, Yang D, Cosgrove DP, Xu R. Pattern of distant metasta-
ses in colorectal cancer: a SEER based study. Oncotarget. 2015;6:
38658-38666.
13. Yaeger R, Cowell E, Chou JF, et al. RAS mutations affect pattern of
metastatic spread and increase propensity for brain metastasis in
colorectal cancer. Cancer. 2015;121:1195-1203.
14. Michl M, Heinemann V, Jung A, Engel J, Kirchner T, Neumann J.
Expression of cancer stem cell markers in metastatic colorectal cancer
correlates with liver metastasis, but not with metastasis to the central
nervous system. Pathol Res Pract. 2015;211:601-609.
15. Farnell GF, Buckner JC, Cascino TL, O'Connell MJ, Schomberg PJ,
Suman V. Brain metastases from colorectal carcinoma. The long term
survivors. Cancer. 1996;78:711-716.
16. Tan WS, Ho KS, Eu KW. Brain metastases in colorectal cancers. World
J Surg. 2009;33:817-821.
17. Imaizumi J, Shida D, Narita Y, et al. Prognostic factors of brain metas-
tases from colorectal cancer. BMC Cancer. 2019;19:755.
18. Chyu n Y, Hayward E, Lokich J. Metastasis to the central nervous
system from colorectal cancer. Med P ediatr Oncol. 1980;8:
305-308.
19. Kohne CH, Cunningham D, Di Costanzo F, et al. Clinical determinants
of survival in patients with 5-fluorouracil-based treatment for meta-
static colorectal cancer: results of a multivariate analysis of 3825
patients. Ann Oncol. 2002;13:308-317.
20. Ko FC, Liu JM, Chen WS, Chiang JK, Lin TC, Lin JK. Risk and patterns
of brain metastases in colorectal cancer: 27-year experience. Dis
Colon Rectum. 1999;42:1467-1471.
21. Jung M, Ahn JB, Chang JH, et al. Brain metastases from colorectal
carcinoma: prognostic factors and outcome. J Neurooncol. 2011;101:
49-55. |
---|